SBIR/STTR – DOD Workshop by CTNext
A workshop to educate entrepreneurs interested in non-dilutive federal funding from SBIR and STTR, with a focus on the DOD. About this event Please...
A workshop to educate entrepreneurs interested in non-dilutive federal funding from SBIR and STTR, with a focus on the DOD. About this event Please...
Join us as we discuss the ACA employer mandate and its rules on administering offers of coverage when a change in employment status occurs. The...
Online registration is available until: 1/12/2022 Join WIB-Connecticut for an evening of wine and cheese! Our host and sommelier, Peter Klann from The Good Food Project, will...
In the world of business, careers are no longer linear or predictable. What was once a clearly sign-posted path as you progressed through milestones, a...
It’s been one year since the passage of the IRA. The Centers for Medicare & Medicaid Services has moved forward implementing the law’s various provisions, including the new Medicare negotiation program and the redesign of the Medicare Part D benefit. Learn the latest developments from our panel of experts, including how the IRA is impacting biopharmaceutical companies today. Panelists will delve into other important issues beyond the IRA, including new developments in Medicaid, 340B, and the emergence of Prescription Drug Affordability Boards in a number of states.
Moderator:
John Murphy, Chief Policy Officer, BIO
Speakers:
Crystal Kuntz, SVP, Health Policy & Reimbursement, BIO
Erin Hertzog, Partner, Foley Hoag LLP
Jim Meyers, Senior Advisor, BCG